Endocytosis of Trk (tropomyosin-related kinase) receptors is critical for neurotrophin signal transduction and biological functions. However, the mechanism governing endocytosis of TrkB (tropomyosin-related kinase B) and the specific contributions of TrkB endocytosis to downstream signaling are unknown. In this study, we report that blocking clathrin, dynamin, or AP2 in cultured neurons of the central nervous system inhibited brain-derived neurotrophic factor (BDNF)-induced activation of Akt but not ERK. Treating neurons with the clathrin inhibitor monodansylcadaverine or a peptide that blocks dynamin function specifically abrogated Akt pathway activation in response to BDNF but did not affect the response of other downstream effectors or the up-regulation of immediate early genes neuropeptide Y and activity-regulated cytoskeletonassociated protein. Similar effects were found in neurons expressing small interfering RNA to silence AP2 or a dominant negative form of dynamin that inhibits clathrin-mediated endocytosis. In PC12 cells, ERK but not Akt activation required TrkA endocytosis following stimulation with nerve growth factor, whereas the opposite was true when TrkA-expressing neurons were stimulated with nerve growth factor in the central nervous system. Thus, the specific effects of internalized Trk receptors probably depend on the presence of cell type-specific modulators of neurotrophin signaling and not on differences inherent to Trk receptors themselves. Endocytosis-dependent activation of Akt in neurons was found to be critical for BDNF-supported survival and dendrite outgrowth. Together, these results demonstrate the functional requirement of clathrin-and dynamindependent endocytosis in generating the full intracellular response of neurons to BDNF in the central nervous system.
sary for the activation of some Trk downstream pathways but not others.
It is currently unknown whether other neurotrophins-Trk complexes, such as BDNF-TrkB, depend on endocytosis for the activation of selective downstream signaling cascades. In the central nervous system, TrkB is widely expressed in cortical and hippocampal pyramidal neurons as well as cerebellar granule cells, whereas TrkA is restricted to small populations of neurons in other brain regions (11, 12) . Endocytosis of BDNF-TrkB complexes has been reported. In cultured hippocampal neurons, exogenous BDNF promotes a rapid translocation of AP2 (adaptor protein 2) and clathrin to the plasma membrane (13) , and both neuronal activity and Ca 2ϩ influx facilitate TrkB endocytosis in the presence of BDNF (14) . In cultured sensory neurons, BDNF induces rapid endocytosis and retrograde movement of TrkB in axons (15) . In the present study, we report that BDNF-induced TrkB endocytosis in cultured neurons of the central nervous system depends on clathrin, dynamin, and AP2, and blocking endocytosis prevents BDNFinduced activation of Akt but not ERK. Endocytosis inhibitors likewise block NGF-induced Akt activation in TrkA-expressing neurons of the central nervous system, whereas Erk activity is unaffected, the opposite effect as that observed in PC12 cells. Furthermore, we show that TrkB endocytosis is required for BDNF-induced neuronal protection and dendritic growth but not the up-regulation of neuropeptide Y (NPY) and activityregulated cytoskeleton-associated protein (ARC). Together our results demonstrate that activation of Akt signaling downstream of TrkB relies on ligand-receptor endocytosis for its initiation, and BDNF-TrkB endocytosis is a required step in the regulation of biological functions.
EXPERIMENTAL PROCEDURES
Primary Cortical and Hippocampal Neuron Cultures-Cortical and hippocampal neurons were prepared from embryonic day 18 rat embryos and maintained for 10 -12 days in vitro as described previously (16) . Primary cultures of hippocampal and cortical neurons were plated on poly-D-lysine-coated 6-well plates at 1.5 ϫ 10 6 cells/well for biochemical experiments or on poly-D-lysine-coated coverslips at 5,000 cells/coverslip for microscopic analysis. All cell culture reagents were purchased from Invitrogen. Two hours prior to experimentation, cells were rinsed with serum-free media and then incubated in serum-free conditions. Monodansylcadaverine (MDC; 50 M; Sigma) or dynamin proline-rich domain peptide (Dyn-pep; 50 M; Princeton BioMolecules) was applied to the bath for 30 min prior to BDNF treatment (25 ng/ml; Sigma) to inhibit clathrin and dynamin, respectively. Cultures were treated with Trk inhibitor K252a (200 nM; Sigma), MEK1 inhibitor PD98059 (10 M; Sigma), or PI3K/Akt inhibitor LY294002 (50 M; Sigma) for 30 min prior to BDNF treatment. All pharmacological agents were dissolved in DMSO, and control cultures were stimulated with the same amount of DMSO solution. The Animal Experiment Committee of Shanghai Institutes for Biological Sciences approved all experimental procedures.
Primary Cerebellar Granule Neuron Cultures-Cerebellar granule cells were prepared from P6 rats as described previously (17) . Cerebella were dissected and then incubated for 20 min at 37°C in phosphate-buffered saline (PBS) containing 10 mM glucose, 10 mg/ml DNase, and 0.5 mg/ml papain. Cells were carefully dissociated by triturating through a plastic pipette, pelleted at 900 ϫ g for 5 min, and resuspended in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. The medium was changed after 24 h to serum-free medium with or without BDNF (25 ng/ml) for the cell survival assay. Cerebellar granule cell lysate used for Western blotting was collected after 3-4 days in vitro.
Biotinylation Assay-Following treatments, cultures were quickly rinsed in ice-cold PBS-Ca-Mg (PBS, pH 7.4, containing 1 mM CaCl 2 and 0.5 mM MgCl 2 ). Cell surface proteins were biotinylated for 60 min with sulfosuccinimidyl-6-(biotinamido)hexanoate (Sulfo-NHS-LC-Biotin; 0.25 mg/ml; Pierce) diluted in PBS-Ca-Mg. Biotinylation was stopped by removing the biotin solution and washing cultures with 10 mM ice-cold glycine in PBS-Ca-Mg for 20 min. Cells were then lysed with radioimmune precipitation buffer, and biotinylated proteins were precipitated with ImmunoPure Immobilized Streptavidin (25 l; Pierce) by constant mixing overnight at 4°C. Biotinylated protein precipitates were washed with radioimmune precipitation buffer and processed for Western blotting analysis. Experiments were performed in triplicate.
Enzyme-linked Immunosorbent Assay (ELISA)-ELISAs were performed in 96-well plates. Following treatment, cultures were fixed and incubated with anti-TrkB (N-20; 1:50; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) for 3 h at 37°C. Cultures were then washed and incubated with horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (1:1,000; Pierce). For end point assays, the level of surface TrkB was measured by a ready-to-use peroxidase substrate containing 2,3Ј-azino-bis (3-ethylbenz-thiazoline-6-sulfonic acid; Sigma). Absorbance was read at 405 nm.
Transfection of Primary Cultured Neurons-Hippocampal neurons grown on glass coverslips (Corning) for 7 days were transfected with the full-length TrkB-GFP, truncated TrkB-GFP constructs (kindly provided by Dr. Rosalind A Segal), wildtype dynamin, and dominant negative dynamin constructs (kindly provided by Dr. Bai Lu). Constructs were mixed with 250 mM CaCl 2 and an equal volume of 2ϫ Hepes-buffered saline (274 mM NaCl, 10 mM KCl, 1.4 mM Na 2 HPO 4 , 15 mM D-glucose, and 42 mM Hepes, pH 7.06). The DNA-calcium complex was incubated for 20 min and added to cultures for 1 h in Dulbecco's modified Eagle's medium without glutamine. After transfection, hippocampal neurons were washed three times with Dulbecco's modified Eagle's medium and transferred to the original medium. We used the Amaxa Nucleofector device (Amaxa Biosystems) to transfect cerebellar granule neurons for the neuronal survival assay and to transfect primary hippocampal neurons for MAP2 staining. Transfection of primary neurons with GFP, Bcl2-GFP, HA-tagged wild type, and constitutively active Akt constructs (kindly provided by Dr. Alfonso Bellacosa (18) ) was carried out immediately after dissociation. Plasmids (5 g of each) were introduced into dissociated neurons by electroporation using the Amaxa Nucleofector before plating onto 35-mm dishes according to the manufacturer's recommendations. Transfection efficiencies were determined in each experiment by GFP fluorescence, and only cultures with more than 75% of cells transfected were considered for analysis. We also examined transfection efficiency by Western blotting with anti-HA tag or anti-GFP antibodies.
Single Cell Fluorescence Imaging-Forty-eight hours after calcium phosphate transfection of full-length or truncated TrkB-GFP constructs, hippocampal neurons were mounted onto a heated stage (37°C) on the confocal microscope (Zeiss LSM 510) and incubated in 25 ng/ml BDNF for 5-30 min. GFP fluorescence was visualized under 488-nm wavelength light. Z-series stacks of confocal fluorescence images were acquired with consecutive optic slices (1-m interval) and reconstructed with the LSM Image Browser. At least eight neurons were captured per condition in each experiment. Statistical significance (p Ͻ 0.05) was assessed using Student's t test.
AP2 RNAi Lentivirus Generation-AP2-targetting oligonucleotides were designed and generated from full-length rat AP2 by Shanghai GeneChem Co., Ltd. After testing knockdown efficiencies, stem-loop DNA oligonucleotides were synthesized by Shanghai GeneChem Co. Ltd. (sense, 5Ј-TAA GAA AGT CCA GCA TTC AAA TTT CAA GAG AAT TTG AAT GCT GGA CTT TCT TTT TTT TC-3Ј; antisense, 5Ј-TCG AGA AAA AAA AGA AAG TCC AGC ATT CAA ATT CTC TTG AAA TTT GAA TGC TGG ACT TTC TTA-3Ј) and cloned into the lentivirus-based RNAi vector PsicoR (Addgene). A nontargeting stem-loop DNA PsicoR vector was also generated for use as a negative control. Lentiviral particles were prepared as described previously (19) . Neurons were infected with AP2-RNAi-lentivirus or negative control virus at 7 days in vitro and examined at 10 days in vitro.
Western Blotting and Antibodies-Cultured neurons were lysed in ice-cold radioimmune precipitation lysis buffer (0.1% SDS, 1% Nonidet P-40, 50 mM HEPES, pH 7.4, 2 mM EDTA, 100 mM NaCl, 5 mM sodium orthovanadate, 40 M p-nitrophenyl phosphate, 1% protease inhibitor mixture set I (Calbiochem) after treatments. Whole cell lysates or biotinylated fractions were mixed with sample buffer for SDS-PAGE. The following antibodies were used: rabbit anti-phospho-TrkA (Tyr 490 ) (1:1,000; Cell Signaling Technology), rabbit anti-TrkB (H-181) (1:500; Santa Cruz Biotechnology), rabbit anti-phospho-Akt1/ 2/3 (1:1,000; Santa Cruz Biotechnology), rabbit anti-Akt1/2/3 (1:1,000; Cell Signaling Technology), rabbit anti-phospho-ERK1/2 (1:2,000; Cell Signaling Technology), rabbit anti-ERK1/2 (1:2,000; Cell Signaling Technology), anti-phospho-PLC␥1 T783 (1:1,000; Cell Signaling Technology), anti-PLC␥1(1:1,000; Cell Signaling Technology), anti-phospho-CREB (1:1,000; Cell Signaling Technology), rabbit anti-CREB (1:1,000; Cell Signaling Technology), rabbit anti-GFP (1:1,000; Santa Cruz), mouse anti-HA tag (1:2000; Sigma), and mouse anti-actin (1:2000; Sigma). Horseradish peroxidase-conjugated goat anti-rabbit or goat anti-mouse secondary antibodies (1:10,000; Pierce) were used. Immunoreactive bands were visualized by enhanced chemiluminescence (ECL; Pierce). Densitometric analysis was conducted using ImageQuant 5.2 software (Amersham Biosciences), and statistical evaluations were assessed by one-way analysis of variance followed by Student's t test (p Ͻ 0.05 was considered significant). Each experiment was repeated at least three times.
Reverse Transcription-PCRs-The TRIZOL reagent kit (Invitrogen) was used to isolate mRNA from cultured neurons. First-strand synthesis and PCR were performed using Moloney murine leukemia virus reverse transcriptase and tag polymerase (Promega) according to the manufacturer's instructions. Primer sets used were as follows: ARC, 5Ј-CCG CCG GCT CTG AAT CC-3Ј and 5Ј-AAG TTG TTC TCC AGC TTG CCC-3Ј; NPY, 5Ј-TGT GGA CTG ACC CTC GCT CTA-3Ј and 5Ј-ATT GGG TGG GAC AGG CAG AC-3Ј; AP2, 5Ј-CGG TGG GTT ACT GGT GGA-3Ј and 5Ј-AAC TGC GTG GAG GTC TTG-3Ј; glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 5Ј-ACC ACA GTC CAT GCC ATC AC-3Ј and 5Ј-TCC ACC ACC CTG TTG CTG TA-3Ј.
Cell Survival Assay-Cell death was detected by enzymatic labeling of DNA strand breaks using the ApopTag peroxidase in situ apoptosis detection kit (Chemicon) following the manufacturer's instructions. Briefly, neurons were grown on coverslips for 24-well chambers. After treatment, medium was removed, and neurons were washed three times with PBS. Cells were fixed in 1% paraformaldehyde for 10 min at room temperature and washed three times in PBS. Neurons were permeabilized in ethanol/acetic acid (2:1), washed in PBS, and then incubated with TUNEL solution (TdT and digoxigenin-dUTP) in humidified atmosphere at 37°C for 60 min. The reaction was terminated by rinsing with PBS prior to incubation with peroxidase-conjugated anti-digoxigenin antibody (1:2000) for 60 min. To visualize the immunocomplexed peroxidase, substrate solution (75 l) was added. The experiment was repeated three times in duplicate. TUNEL labeling was quantified by counting the number of positively stained neurons per 100 cells for each treatment group. Values are represented as the mean percentage of positively stained cells Ϯ S.E. The survival of cerebellar granule neurons was also estimated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide colorimetric assay (20) .
Immunocytochemical Staining and Fluorescence Microscopy-Hippocampal neurons grown on glass coverslips (Corning Glass) for 7 days were transfected with GFP, HA-tagged wild type dynamin, and dominant negative dynamin constructs by the calcium phosphate method. Forty-eight hours later, transfected neurons were stimulated with BDNF (25 ng/ml for 10 min), fixed, and then incubated overnight at 4°C with rabbit anti-phospho-Akt1/2/3 (1:200; Santa Cruz Biotechnology) or rabbit anti-phospho-ERK (1:100; Cell Signaling Technology) and mouse anti-HA (1:1000; Sigma) in PBS containing 0.2% goat serum. Cultures were washed and incubated with Alexa Fluor 546-and 488-conjugated secondary antibodies (Molecular Probes) diluted in PBS containing 0.2% goat serum for 1 h at room temperature. Images were acquired under a Zeiss confocal microscope (magnification ϫ40; 488-and 546-nm laser). For the dendritic growth assay, transfection of hippocampal neurons was carried out immediately after dissociation using the Amaxa Nucleofector device. Anti-MAP2 (1:1000; Chemicon) and anti-HA (1:1000; Sigma) were used in the following immunocytochemical procedures. The number of the primary dendrites per neuron was counted from confocal images, and the total dendrite length was determined by tracing all dendritic processes in Neurolucida software. At least 25 neurons were quantified per condition in each experiment, and each experiment was repeated for at least three times. Statistical significance (p Ͻ 0.05) was assessed using a paired Student's t test.
RESULTS
BDNF Induces TrkB Endocytosis in a Clathrin-and Dynamindependent Manner-We began our investigation of BDNF-TrkB endocytosis by performing a surface biotinylation assay to measure surface expression of TrkB in cultured cortical neurons when exposed to BDNF. Cells were stimulated with 25 ng/ml BDNF for 0 -60 min and then incubated with biotin for 60 min. Biotin-conjugated surface proteins were fractionated on an immobilized streptavidin column, and the amount of surface-TrkB was measured by blotting the biotin fraction with anti-TrkB and comparing it with total TrkB in whole cell lysate ( Fig. 1A) . Within 15 min of BDNF exposure, a reduction in surface-expressed TrkB was apparent, and the biotinylated fraction was reduced by about 39% (Fig. 1B, top) . After 60 min of exposure, only 38% remained at the surface (Fig. 1B, top) , but no change in total TrkB expression was observed ( Fig. 1A) . We further confirmed this finding by ELISA with an antibody specific for the extracellular domain of TrkB. Approximately 33% of cell surface TrkB was internalized by 15 min after BDNF application, and only 45% remained at the surface after 60 min (Fig. 1B,  bottom) . These results are reminiscent of NGF-induced TrkA endocytosis in PC12 cells (6) and suggest that TrkB receptors are endocytosed in response to exogenous BDNF stimulation.
To visualize TrkB receptor relocalization, we expressed a GFPtagged, full-length TrkB fusion protein in cultured hippocampal neurons and monitored the response to BDNF stimulation by time lapse imaging. TrkB-GFP was observed to undergo endocytosis within 5 min of exposure to 25 ng/ml BDNF (data not shown). Movement from the cell surface into intracellular compartments accelerated in the following minutes, and 10 min after application of BDNF, cell surface-localized GFP signals (within 2 m of the plasma membrane) had decreased by 42%, whereas fluorescence had increased by 51% in the medulla (Fig. 1, C (a  and c) and D (top)). In contrast, we did not observe GFP internalization into hippocampal neurons transfected with a GFPtagged, truncated TrkB receptor lacking the cytoplasmic domain (T-TrkB) in response to BDNF exposure ( Fig. 1, C (b  and d) and D (bottom)), even after 30 min (data not shown).
NGF-induced endocytosis of TrkA is both clathrin-and dynamin-dependent in PC12 cells, and BDNF can rapidly increase AP2 and clathrin translocalization to the plasma membrane (13) . We therefore examined whether inhibiting the assembly of the clathrin coat of endosomes with the putative inhibitor MDC (21) could block TrkB internalization. We found that bath application of 50 M MDC to cortical neuron cultures for 30 min prior to BDNF stimulation completely blocked TrkB endocytosis (Fig. 1, E and F) . Pretreatment with Dyn-pep (50 M) (22) for 30 min also blocked BDNF-induced TrkB endocytosis (Fig. 1, E and F) .
BDNF-induced PI3K/Akt Activation Requires Clathrin-, Dynamin-, and AP2-mediated Endocytosis-We next examined whether endocytosis of TrkB is required for downstream signaling. Interestingly, pretreating primary cortical neuron cultures with MDC prevented a sustained BDNF-induced Akt activation (Fig. 2, A and B, top) , as did Dyn-pep ( Fig. S1 ), without significantly affecting the activation of TrkB, SHC, ERK, PLC␥, or cAMP-response element-binding protein (Fig. 2, A and B, bottom). Neither MDC nor Dyn-pep affected basal phosphorylation levels of any of these proteins (data not shown). In primary hippocampal neuron cultures and cerebellar granule cells, we similarly found that inhibition of endocytosis by bath application of either MDC or Dyn-pep selectively prevented BDNF-induced Akt activation, without affecting the activation of TrkB and ERK (Fig. 3, B and C) (data not shown). As expected, the tyrosine kinase inhibitor K252a (23) completely blocked BDNF-induced activation of TrkB, Akt, and ERK.
In support of these findings, cultured hippocampal neurons stained with an antibody specific to phosphorylated Akt were more robustly labeled following 10 min of BDNF stimulation than at rest. However, staining intensity of phosphorylated Akt (pAkt) was not increased in response to BDNF in cells transfected with a construct expressing HA-tagged, dominant negative dynamin (K44E-dynamin; Fig. S2, A  and B) , which is known to inhibit clathrin-mediated endocytosis (24) . In contrast, staining of phosphorylated ERK (pERK) was not affected by K44E-dynamin expression (Fig. S2, A and B) . Transfecting with wildtype dynamin did not alter the levels of pAkt or pERK after BDNF application (Fig. S2, A and B) . To further confirm our results, we used a lentivirus-based RNAi delivery system to infect cultured hippocampal neurons with short interfering RNAs targeting clathrin AP2, a critical regulator of endocytosis. AP2 short interfering RNA markedly reduced the expression of AP2 protein and mRNA compared with nontarget control RNAi (Fig. 3A) and blocked BDNF-induced activation of Akt but not ERK (Fig. 3, B and D) . Taken together, these results demonstrate that BDNF-induced PI3K/Akt activation in the central nervous system requires clathrin-dependent endocytosis of TrkB.
Given the divergent effects of endocytosis on the activation of ERK and Akt pathways by BDNF/TrkB signaling in cultured neurons and by NGF/TrkA in PC12 and DRG cells and sympathetic neurons (9), we set out to determine whether cell type plays a determinant role in the mechanism of activation of neurotrophin signaling. We first confirmed that 50 M MDC and 50 M Dyn-pep indeed blocks NGF-induced activation of ERK, but not Akt, in PC12 cells (Fig. S2C) . We next transfected cortical neurons with wild type TrkA and found that NGF-induced activation of Akt, but not ERK, was inhibited by MDC and Dynpep (Fig. S2D) . These results demonstrate that the selective effect of Trk endocytosis on downstream signaling pathways is dependent on cell type rather than differences in the intrinsic properties of Trks. 
BDNF-induced Up-regulation of NPY and ARC Does Not
Require Clathrin-mediated Endocytosis-BDNF activity regulates the expression of a multitude of genes (25) . To examine whether endocytosis of TrkB is required for BDNF-induced gene expression, we investigated the effect of BDNF on the expression of two immediate early genes, ARC and NPY, under conditions of endocytic blockade. Reverse transcription-PCR analysis revealed that 3-h stimulation with BDNF (25 ng/ml) led to expression of ARC and NPY mRNA. This up-regulation was blocked by K252a (200 nM) and MEK1 inhibitor PD98059 (10 M) but not, however, by MDC and Dyn-pep (Fig. 4, A and  B) . The PI3K inhibitor LY294002 (50 M) also had no effect on BDNF-induced ARC and NPY expression. Thus, ARC and NPY up-regulation are not dependent on clathrin-mediated TrkB endocytosis or PI3K/Akt signaling but instead are likely to be driven by the activity of MEK/ERK signaling and possibly other pathways regulated by BDNF.
BDNF-dependent Neuronal Protection Requires Clathrinmediated Endocytosis-Akt is a downstream target of PI3K and a critical mediator of growth factor-induced neuronal survival. Previous studies have demonstrated that BDNF/TrkB-dependent survival of cultured neurons under serum deprivation depends on PI3K/Akt activity and, to a lesser extent, on MEK activity (26, 27) . We hypothesized that TrkB endocytosis is thus necessary for BDNF-dependent neuronal survival. To test this, we deprived cultured cerebellar granule cells of serum and measured the neuroprotective effect of BDNF in the presence of endocytosis inhibitors. TUNEL staining revealed a significant increase in apoptosis 24 h after deprivation, and application of BDNF dramatically attenuated apoptosis of serumstarved granule neurons (Fig. 5A ). Treatment with MDC (50 M) or Dyn-pep (50 M) significantly reduced the protective effect of BDNF (Fig. 5, A and B) , whereas the inhibitors themselves did not have a significant effect on neuronal survival (data not shown). Expression of HA-tagged, constitutively active Akt (CA-Akt) also significantly alleviated apoptosis in serum-free medium even in the absence of BDNF, and expression of CA-Akt in the presence of MDC rescued the protective effect of BDNF (Fig. 5, C and D) . Furthermore, inhibition of PI3K/Akt with the inhibitor LY294002 (50 M) abolished the protective effect of BDNF (Fig. 5B) , and the MEK1 inhibitor PD98059 (10 M) partially blocked the effect of BDNF (Fig. 5B) . These data indicate that clathrin-mediated endocytosis of TrkB and subsequent PI3K/Akt activation is required for the neuroprotective effect of BDNF.
BDNF-induced Dendritic Growth Requires Clathrin-mediated Endocytosis-PI3K/Akt signaling also regulates dendrite growth and arborization downstream of BDNF (28) . 2 days in vitro hippocampal cultures exposed to BDNF for 48 h significantly increased total dendrite length and branch points, as revealed by MAP2 staining (Fig. 6A) . Blocking clathrin-dependent endocytosis with MDC or Dyn-pep abolished BDNF-induced dendritic growth (Fig. 6, A and B) , whereas expression of CA-Akt greatly promoted dendritic growth in the absence of BDNF and rescued the effect of BDNF in the presence of MDC (Fig. 6C) . In contrast, overexpressing wild-type Akt did not rescue BDNF-mediated dendritic growth in the presence of MDC ( Fig. 6D ). BDNF-induced dendrite growth was also inhibited by MDC in hippocampal neurons expressing GFP-tagged Bcl2 (Fig. S3, A-D) . Thus, endocytosis-dependent activation of PI3K/Akt signaling directly affects dendrite growth and is not simply an indirect effect of enhanced cell survival. These results suggest that TrkB endocytosis is required for BDNF-induced dendritic growth.
DISCUSSION
This study investigated the mechanism and functional consequences of BDNF-induced TrkB endocytosis in neurons of the central nervous system. Four principle findings emerged: 1) stimulation with BDNF induced TrkB endocytosis in cultured primary cortical, hippocampal, and cerebellar granule neurons; 2) clathrin, dynamin, and AP2 were all required for TrkB endocytosis; 3) endocytosis was required for BDNF-induced activation of PI3K/Akt but not MEK/ERK or PLC␥ in all central nervous system neuronal cell types investigated; 4) endocytosis was required for BDNFinduced neuron survival and dendrite growth but not TrkBmediated up-regulation of immediate early genes.
Several studies have reported the importance of Trk endocytosis in regulating NGF signaling. Endocytosis of TrkA is required for downstream activation of ERK signaling in PC12 cells, dorsal root ganglion cells, and sympathetic neurons (8, 9) . Binding of NGF to TrkA triggers the recruitment of receptors to clathrin-coated pits, leading to the formation of clathrincoated vesicles and entry into the endocytic pathway (13, 29) . It is now known that clathrin-coated vesicles also contain signaling molecules, including proteins involved in the Ras-MAP kinase pathway, that serve as a platform for ERK activation (29) . Accordingly, blocking TrkA endocytosis selectively inhibits NGF-induced activation of ERK in PC12 cells but does not, however, affect Akt activation (9) . Surprisingly, we found that blocking endocytosis selectively inhibited NGF-induced Akt activation, but not ERK activation, in TrkA-expressing neurons of the central nervous system, indicating that NGF-TrkA signaling differs fundamentally in its dependence on endocytosis in different cell types. Thus, the selective effects of Trk endocytosis on downstream signaling cascades are not likely to be dependent on inherent differences in the physiological properties of Trk receptors but rather depend on the partnership with unique adaptor proteins.
Isoforms of Trk receptors lacking the intracellular tyrosine kinase domain are expressed in numerous cell types and have been found to be biologically active. Truncated TrkB and TrkC do not support the activation of canonical downstream signal cascades but can bind to both neurotrophins and full-length Trks, thereby inhibiting neurotrophin signaling. In addition to dominant negative effects, truncated Trks can also elicit noncanonical intracellular responses (30 -32) . Previous studies have shown that truncated TrkB can bind to and internalize with BDNF (33), possibly by dimerizing with full-length TrkB, and internalization of truncated TrkB can be regulated by neuronal activity (14, 34, 35) . As shown in Fig. 1 , BDNF induced rapid and robust endocytosis of full-length TrkB but failed to induce obvious endocytosis of truncated TrkB, even after 30 min of BDNF stimulation. However, it is possible that the kinetics of truncated TrkB endocytosis in hippocampal neurons are much slower than full-length Trks and were thus not detected during our observation period. Indeed, it has been shown that in cultured 3T3 NIH fibroblast cells, truncated TrkB-dependent BDNF internalization occurs slowly and peaks at 90 min after BDNF stimulation (36) . In cultured astrocytes, internalization of BDNF is undetectable by 30 min of stimulation, but uptake slowly takes effect thereafter, reaching a steady-state level by 120 -240 min (33) .
BDNF-induced activation of the PI3K/Akt pathway plays an important role in a diversity of cellular functions, such as pro-moting cell survival and dendrite morphogenesis. BDNF-TrkB signaling is capable of rescuing cultured neurons from apoptosis when grown in conditions of low potassium or in serum-free medium. Our findings confirm the essential role of PI3K/Akt signaling in protecting serum-deprived cerebellar granule cells and demonstrate that TrkB endocytosis is also necessary for the protective effect of BDNF. Pharmacological blockers of clathrin and dynamin were all able to reverse the protective effect of BDNF on serum-deprived granule cells. However, constitutive activation of the PI3K/Akt pathway with CA-Akt precluded the inhibitory effect of endocytotic blockade.
Previous studies have uncovered the importance of neurotrophins for dendrite morphogenesis (28, 37) . We confirmed the effect of BDNF on dendritic outgrowth and demonstrated that this effect is dependent on endocytosis. Blockade of clathrin-dependent endocytosis repressed the effects of BDNF in cultured hippocampal neurons, thus revealing the importance of the PI3K/Akt pathway in mediating the growth response of dendrites to BDNF. Recently, it has been demonstrated that activation of both PI3K/ Akt and MEK/ERK pathways contributes to the formation of primary dendrites in response to BDNF (37) . Our present data would suggest that PI3K/Akt signaling alone is sufficient for BDNFdependent growth, since blockade of endocytosis with MDC completely abrogated the response to BDNF. Furthermore, expression of CA-Akt had the same growth-enhancing effect as BDNF, and applying BDNF to CA-Akt-expressing cells did not promote further dendrite outgrowth. These data together suggest that endocytosis-dependent activation of PI3K/Akt signaling is both necessary and sufficient for BDNF-induced neuronal survival and dendrite outgrowth.
